We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study.
- Authors
Vitolo, U; Bertini, M; Brusamolino, E; Cavallero, G B; Comotti, B; Gallo, E; Ghio, R; Levis, A; Luxi, G; Meneghini, V
- Abstract
The prognosis of advanced-stage diffuse large-cell lymphoma (DLCL) has improved with the use of the third-generation regimens such as methotrexate with leucovorin, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOP-B). However, different results have been reported. Therefore, we started a cooperative study to confirm the efficacy of MACOP-B. An analysis of prognostic factors was also performed to identify poor-prognosis patients.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Vol 10, Issue 2, p219
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1992.10.2.219